SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ProMetic Life Sciences
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (55)1/5/2017 6:54:06 AM
From: Leo Fisher  Read Replies (1) of 250
 
I get the high market cap / hemorrhaging of cash, but that's not unusual for this stage of R&D. The fact that they are Canadian coming into the US market doesn't help either, but I think what makes these guys interesting is the diversification and actual income (minimal as it is for now) that they derive from their plasma. 4050 is showing good results so far (knock on wood) and although still not in PIII I would be hesitant to bet against something that could go blockbuster and compete with Roche's Esbriet, which they didn't buy cheaply. I get the risks / long timeline associated with this stock and its definitely a speculative investment but I also wouldn't trade that in for the unlimited risk you get when shorting something like this.

Once you finish your look I'd be interested in your opinion; I don't have medical background but I have several family members who do and they are impressed with the tech these guys wield.

Not sure where I would value them at this point. Most of the analyst have it somewhere between 4-6 and that seems reasonable if all goes to plan; based of potential sales of $450-$800. From what I remember ITMN was bought at $8.3 billion for what was estimated to be $1 billion yearly sales at the time.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News